Phase 1 Mesothelioma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with an advanced, inoperable, or spreading solid tumour that has been confirmed by a lab test (pathology).
- Your cancer is one of several types of interest, including breast, bladder, cervical, colorectal, oesophageal, head and neck, kidney, ovarian, sarcoma, thymoma, or uterine cancer (other types may also be considered).
- You have already tried standard treatments, were unable to tolerate them, or have chosen not to pursue them — this may include targeted therapies, immunotherapy, or chemotherapy.
- Your cancer can be measured on scans according to a standard set of guidelines (called RECIST 1.1).
- You have at least one tumour that doctors can safely inject into or take a biopsy from.
- You are generally well enough to carry out light activity and care for yourself (this is assessed using a standard fitness scale — confirm with trial site).
- Your liver, kidneys, and other organs are working well enough to meet the trial's requirements (confirm with trial site).
- You are willing and able to follow all trial procedures and aftercare instructions.
- Additional eligibility requirements may also apply (confirm with trial site).
Who may not be able to join:
- You have recently received certain cancer treatments and have not yet waited the required amount of time since finishing them (the exact waiting period depends on the treatment type — confirm with trial site).
- You are taking blood-thinning or anti-clotting medications that cannot be safely stopped for the biopsies or injections required by the trial.
- You have cancer that has spread to the brain or the lining around the brain/spine, and it has not been fully removed by surgery or treated with radiation.
- You have a previous history of inflammation of the heart muscle (myocarditis).
- You have HIV/AIDS, or a currently active hepatitis B or hepatitis C infection.
- You are taking high-dose medications that suppress your immune system, or you have a significant problem with your immune system (for example, if you have had an organ transplant).
- Additional reasons that may prevent participation also exist (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +13057722084
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of adverse events with VET3-TGI alone or in combination with atezolizumab; Incidence of dose limiting toxicities reported with VET3-TGI alone or in combination with atezolizumab; Determine the recommended Phase 2 dose
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.